Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer.

  title={Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer.},
  author={J Y Yiannakou and Paul Newland and Francis Calder and A. Kingsnorth and Jonathan Michael Rhodes},
  volume={349 9049},
BACKGROUND Serological tests for pancreatic cancer are little used, partly because such assays have proved insufficiently specific for screening. However, retrospective studies have reported results that compare well with commonly used scanning techniques. In this prospective study we assessed a new type of combined lectin/antibody enzyme-linked mucin assay, CAM 17.1, in a routine clinical setting. METHODS Clinicians at a 1200-bed teaching hospital were encouraged to request the CAM 17.1… CONTINUE READING


Publications citing this paper.
Showing 1-9 of 9 extracted citations

Early detection of pancreatic cancer.

JOP : Journal of the pancreas • 2012
View 3 Excerpts
Highly Influenced

A novel serum metabolomics-based diagnostic approach to pancreatic cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 2013

CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology • 2009

Similar Papers

Loading similar papers…